comparemela.com

Latest Breaking News On - Stage products - Page 8 : comparemela.com

Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities

Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. iCrowd Newswire 10 Jun 2021, 02:38 GMT+10 \Involved pharmaceutical companies in the Hemorrhoids market are Nivagen Pharmaceuticals Inc. Edesa Biotech, Citius Pharmaceuticals, and others. DelveInsight s Hemorrhoids Pipeline report highlights the details around Hemorrhoids, which are swollen and inflamed veins around the anus or in the lower rectum. The Hemorrhoids report provides a disease overview, pipeline scenario, and therapeutic assessment of the key pipeline therapies in this domain. The Hemorrhoids report also highlights the unmet needs concerning the development of Hemorrhoids. Some of the key highlights of report- Nivagen Pharmaceuticals Inc. initiated a randomized, double-blind, placebo-controlled, multicenter, parallel-group study of the safety and efficacy of Hydrocortisone Acetate Suppositories, 25 mg compared to placebo suppositories

Current Therapies and Emerging Drugs in the Prediabetes Pipeline Soon to Boost the Treatment Outlook

Prominent companies such as Valbiotis, Resverlogix, Caelus Health, SciMar, Boston Therapeutics, MicroBiome Therapeutics, and others are developing potential drug candidates to boost the Prediabetes treatment scenario. Out of all the emerging therapies, the late-stage product TOTUM-63 (VALBIOTIS) has shown promising results and will significantly impact the Prediabetes treatment market.Los Angeles, USA , June 02, 2021 (GLOBE NEWSWIRE) Current Therapies and Emerging Drugs in the Prediabetes Pip

Global Pompe Disease Pipeline Insight Report 2020: Disease Pipeline Analysis, Therapeutic Assessment, Unmet Needs, & Impact of Drugs

Global Inflammatory Pain Market Pipeline Analysis 2021: Therapeutic Assessment, Unmet Needs and Impact of Drugs

Share this article Share this article DUBLIN, March 15, 2021 /PRNewswire/ The Inflammatory Pain - Pipeline Insight, 2021 drug pipelines has been added to ResearchAndMarkets.com s offering. This Inflammatory Pain - Pipeline Insight, 2021, report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Inflammatory Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. The report provides comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Inflammatory Pain pipeline landscape is provided which includes the disease overview and Inflammatory Pain treatment guidelines. The assessment part of the report embraces, in depth Inflammatory Pain commercial assessment

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.